Gilead Gets European Commission Marketing Authorization For HIV-1 Infection Drug
April 25, 2016 at 08:30 AM EDT
Gilead Sciences, Inc. (NASDAQ: GILD) revealed that the European Commission has given its marketing authorization for two doses of ...